LLY vs PLTR: Which Is the Better Buy?
Side-by-side comparison of Eli Lilly and Company and Palantir Technologies Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-07.
Eli Lilly and Company · Healthcare
$934.34
+17.6% upside to fair value
Grade B
High Quality
VS
Palantir Technologies Inc. · Technology
$133.79
-41.7% upside to fair value
Grade C
High Quality
QuantHub Verdict
LLY has more upside to fair value
(+17.6%).
LLY trades at a lower forward P/E
(33.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LLY |
PLTR |
| Current Price |
$934.34 |
$133.79 |
| Fair Value Estimate |
$1,098.43 |
$78.04 |
| Upside to Fair Value |
+17.6%
|
-41.7%
|
| Market Cap |
$882.8B |
$306.6B |
| Forward P/E |
33.1x
|
140.4x
|
| EV / EBITDA |
27.9x
|
151.4x
|
| Price / Sales |
12.2x
|
58.7x
|
| Price / FCF |
65.0x
|
114.0x
|
| Revenue Growth YoY |
+55.5%
|
+84.7%
|
| Gross Margin |
82.7%
|
84.1%
|
| Operating Margin |
46.3%
|
38.1%
|
| Return on Equity |
101.3%
|
32.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.54%
|
0.88%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Eli Lilly and Company is a leading global pharmaceutical firm with a dominant position in the diabetes and obesity markets, driven by its blockbuster GLP-1 drugs Mounjaro and Zepbound which generated $36.5 billion in FY2025. The company reported $65.2 billion in total revenue for 2025, making it the top pharma by revenue globally. It exhibits high business quality with a durable competitive moat …
Palantir Technologies Inc. is a high-growth enterprise software company specializing in data analytics and intelligence platforms for government and commercial clients. The company benefits from a durable competitive moat through its established government contracts, proprietary platforms Gotham and Foundry, and expanding commercial footprint. Palantir's revenue grew 84.7% year-over-year in the m…
Accumulation Zones
| Metric |
LLY |
PLTR |
| Zone Low |
$823.82 |
$58.53 |
| Zone High |
$933.67 |
$66.33 |
| In Buy Zone? |
No
|
No
|